BioPharma Credit plc (BPCR) ORD USD0.01
- Add to watchlist
- Create an alert
- This stock can be held in a
Business summary
BioPharma Credit PLC is a United Kingdom-based closed-ended investment company. The principal activity of the Company is to invest in interest-bearing debt assets with a contractual right to future cash flows derived from royalties or sales of approved life sciences products. The Company's investment objective is to generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve its investment objective predominantly through direct or indirect exposure to debt assets, which include royalty investments, senior secured debt, unsecured debt and credit linked notes. Its diversified portfolio is primarily secured by cash flows derived from sales of approved life sciences products. The Company holds a majority of its investments through its financing subsidiary, BPCR Limited Partnership. Its investment manager is Pharmakon Advisors L.P.
Important dates
General stock information
- EPIC:
- BPCR
- ISIN:
- GB00BDGKMY29
- Market cap:
- $1.08 billion
- Shares in issue:
- 1.23 billion
- Sector:
- No specific Industry
- Exchange:
- London Stock Exchange
- Currency:
- US dollar
- Indices:
- n/a
Contact details
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.